Sobre la empresa

Takeda is a global biopharmaceutical company that is patient-centered, value-based and driven by Research and Development. Our commitment is to improve the health of people worldwide with the goal of a bright future. Our passion and persistence in seeking therapies that can change patients' lives for the better are rooted in the values ​​that have shaped Japan's 240 years of unique history.

Dirección

Green Plaza, Building B’, 59-61 Ag. Konstantinou Str.
Marousi, 15124, Athens

Datos de contacto

Teléfono de información médica
+30 210 6387 800

Sitio web de información médica
https://www.globalmedical.takeda.com/

Correo electrónico de Información Médica
MedinfoEMEA@takeda.com

Efectos secundarios/Reacciones adversas

Adverse Reaction Report
In the event of an adverse reaction from the use of a Takeda medicinal product, please notify us using the following contact details:

Tel .: +30 210 6387 800
email: AE.GRC@takeda.com

Comunicar un efecto adverso por teléfono
+30 210 6387 800

Comunicar un efecto adverso por correo electrónico
AE.GRC@takeda.com

Company Website
https://www.takeda.com/el-gr/

Takeda Hellas productos

Los medicamentos marcados con unestán sujetos a un seguimiento adicional que permite la rápida identificación de nueva información de seguridad. Usted puede contribuir comunicando cualquier efecto secundario que conozca.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Adcetris
(brentuximab vedotin)

Advate
(octocog alfa (human coagulation factor VIII (rDNA)))

Adynovi
(rurioctocog alfa pegol (human coagulation factor VIII (rDNA)))

Alofisel
(darvadstrocel)

Alunbrig
(brigatinib)

Ceprotin
(human protein C)

Circadin
(melatonin)

Controloc
(pantoprazole)

Controloc Control
(pantoprazole)

Elaprase
(idursulfase)

Elityran
(leuprorelin acetate)

Entyvio
(vedolizumab)

Feiba
(factor VIII inhibitor bypassing activity)

Firazyr
(icatibant)

Fosrenol
(lanthanum (III) carbonate hydrate)

Human Albumin Baxalta
(albumin human)

HyQvia
(human normal immunoglobulin (Immune Globulin 10% or IG 10%), recombinant human hyaluronidase (rHuPH20))

Incresync
(alogliptin, pioglitazone)

Kiovig
(human normal immunoglobulin (IVIg))

Matrifen
(fentanyl)

Mezavant
(mesalazine)

Ninlaro
(ixazomib)

Prezolon
(prednisolone)

Prothromplex TOTAL
(factor II (prothrombin), factor VII (proconvertin), factor IX (monoclonal antibody purified), factor X (stuart prower factor), human protein C)

Replagal
(agalsidase alfa)

Resolor
(prucalopride)

Revestive
(teduglutide)

Riopan
(magaldrate anhydrous)

Rixubis
(nonacog gamma)

Takhzyro
(lanadelumab)

Vipdomet
(alogliptin, metformin)

Vipidia
(alogliptin)

VPRIV
(velaglucerase alfa)

Xagrid
(anagrelide)

Xefo Rapid
(lornoxicam)

Zurcazol
(pantoprazole sodium sesquihydrate)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Ultima actualización: 28/03/2023